These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 29110862)
21. Additional Drug Resistance in Patients with Multidrug-resistant Tuberculosis in Korea: a Multicenter Study from 2010 to 2019. Lee T; Lee SJ; Jeon D; Lee HY; Kim HJ; Kang BH; Mok J J Korean Med Sci; 2021 Jul; 36(26):e174. PubMed ID: 34227261 [TBL] [Abstract][Full Text] [Related]
22. Survey of tuberculosis drug resistance among Tibetan refugees in India. Salvo F; Dorjee K; Dierberg K; Cronin W; Sadutshang TD; Migliori GB; Rodrigues C; Trentini F; Di Serio C; Chaisson R; Cirillo DM Int J Tuberc Lung Dis; 2014 Jun; 18(6):655-62. PubMed ID: 24903934 [TBL] [Abstract][Full Text] [Related]
23. Time to Multidrug-Resistant Tuberculosis Treatment Initiation in Association with Treatment Outcomes in Shanghai, China. Chen Y; Yuan Z; Shen X; Wu J; Wu Z; Xu B Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437632 [TBL] [Abstract][Full Text] [Related]
24. The Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant Tuberculosis. Sachdeva KS; Raizada N; Gupta RS; Nair SA; Denkinger C; Paramasivan CN; Kulsange S; Thakur R; Dewan P; Boehme C; Arinaminpathy N PLoS One; 2015; 10(7):e0131438. PubMed ID: 26132584 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples. Meaza A; Kebede A; Yaregal Z; Dagne Z; Moga S; Yenew B; Diriba G; Molalign H; Tadesse M; Adisse D; Getahun M; Desta K BMC Infect Dis; 2017 Apr; 17(1):280. PubMed ID: 28415989 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of Xpert MTB-RIF guided diagnosis and treatment of rifampicin-resistant tuberculosis in Indonesia: A retrospective cohort study. Soeroto AY; Lestari BW; Santoso P; Chaidir L; Andriyoko B; Alisjahbana B; van Crevel R; Hill PC PLoS One; 2019; 14(2):e0213017. PubMed ID: 30818352 [TBL] [Abstract][Full Text] [Related]
28. Overcoming the health system barriers to early diagnosis and management of multidrug-resistant tuberculosis in a rural setting in North India. Bashar MA; Aggarwal A; Bhattacharya S BMJ Case Rep; 2020 Jan; 13(1):. PubMed ID: 31969399 [TBL] [Abstract][Full Text] [Related]
29. Drug sensitivity patterns in Xpert-positive spinal tuberculosis: an observational study of 252 patients. Upadhyay M; Patel J; Kundnani V; Ruparel S; Patel A Eur Spine J; 2020 Jul; 29(7):1476-1482. PubMed ID: 32055960 [TBL] [Abstract][Full Text] [Related]
30. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan. van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387 [TBL] [Abstract][Full Text] [Related]
32. Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India. Sethi S; Mewara A; Dhatwalia SK; Singh H; Yadav R; Singh K; Gupta D; Wanchu A; Sharma M BMC Infect Dis; 2013 Mar; 13():137. PubMed ID: 23497169 [TBL] [Abstract][Full Text] [Related]
33. Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011. Nguyen HB; Nguyen NV; Tran HT; Nguyen HV; Bui QT Western Pac Surveill Response J; 2016; 7(2):35-40. PubMed ID: 27508089 [TBL] [Abstract][Full Text] [Related]
34. Presumptive treatment of multidrug-resistant tuberculosis in household contacts. Parr JB; Rich ML; Keshavjee S; Franke MF; Mitnick CD; Bayona J; Becerra MC Int J Tuberc Lung Dis; 2016 Mar; 20(3):370-5. PubMed ID: 27046719 [TBL] [Abstract][Full Text] [Related]
35. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing. Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132 [TBL] [Abstract][Full Text] [Related]
36. Genetic mutations associated with rifampicin and isoniazid resistance in MDR-TB patients in North-West India. Kumar P; Kumar P; Balooni V; Singh S Int J Tuberc Lung Dis; 2015 Apr; 19(4):434-9. PubMed ID: 25859999 [TBL] [Abstract][Full Text] [Related]
37. Early results of systematic drug susceptibility testing in pulmonary tuberculosis retreatment cases in Cameroon. Noeske J; Voelz N; Fon E; Abena Foe JL BMC Res Notes; 2012 Mar; 5():160. PubMed ID: 22436423 [TBL] [Abstract][Full Text] [Related]
38. Multidrug-resistant tuberculosis in the Kharkiv Region, Ukraine. Butov D; Lange C; Heyckendorf J; Kalmykova I; Butova T; Borovok N; Novokhatskaya M; Chesov D Int J Tuberc Lung Dis; 2020 May; 24(5):485-491. PubMed ID: 32398197 [No Abstract] [Full Text] [Related]
39. A comparison of patient treatment pathways among multidrug-resistant and drug-sensitive TB cases in Delhi, India: A cross-sectional study. Sharma N; Bhatnagar A; Basu S; Khanna A; Chopra KK; Banerjee B; Sharma N; Chandra S; Khanna V; Arora R; Babbar N Indian J Tuberc; 2020 Oct; 67(4):502-508. PubMed ID: 33077051 [TBL] [Abstract][Full Text] [Related]
40. Rapid drug susceptibility testing and treatment outcomes for multidrug-resistant tuberculosis in Peru. Obregón G; Zevallos K; Alarcón V; Puyén ZM; Chávez Inagaki O; Mendoza-Ticona A; Alarcón-Arrascue E; Heldal E; Moore DAJ Int J Tuberc Lung Dis; 2018 Nov; 22(11):1350-1357. PubMed ID: 30355416 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]